These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36008511)

  • 1. SARS-CoV-2 genome variations and evolution patterns in Egypt: a multi-center study.
    Jalal D; Elzayat MG; El-Shqanqery HE; Diab AA; Yahia A; Samir O; Bakry U; Amer K; ElNaqeeb M; Hassan W; Talat HS; Farawela HM; Hamdy MS; Soliman MS; El Sissy MH; Ezzelarab MH; El Khateeb SM; Soliman LH; Haddad SE; Hatem A; Ismail MS; Hossam M; Mansour T; Shalaby L; Soliman S; Hassan R; Hammad M; Abdo I; Magdeldin S; ElHaddad A; Abouelnaga S; Sayed AA
    Sci Rep; 2022 Aug; 12(1):14511. PubMed ID: 36008511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Founder Effect Led Early SARS-CoV-2 Transmission in Spain.
    Díez-Fuertes F; Iglesias-Caballero M; García-Pérez J; Monzón S; Jiménez P; Varona S; Cuesta I; Zaballos Á; Jiménez M; Checa L; Pozo F; Pérez-Olmeda M; Thomson MM; Alcamí J; Casas I
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33127745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of SARS-CoV-2 clades based on signature SNPs unveils continuous evolution.
    Ghosh N; Saha I; Nandi S; Sharma N
    Methods; 2022 Jul; 203():282-296. PubMed ID: 34547443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2021 Jul; 91():104800. PubMed ID: 33677109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 clade dynamics and their associations with hospitalisations during the first two years of the COVID-19 pandemic.
    Päll T; Abroi A; Avi R; Niglas H; Shablinskaja A; Pauskar M; Jõgeda EL; Soeorg H; Kallas E; Lahesaare A; Truusalu K; Hoidmets D; Sadikova O; Ratnik K; Sepp H; Dotsenko L; Epštein J; Suija H; Kaarna K; Smit S; Milani L; Metspalu M; Oopkaup OE; Koppel I; Jaaniso E; Kuzmin I; Inno H; Raudvere U; Härma MA; Naaber P; Reisberg T; Peterson H; Talas UG; Lutsar I; Huik K
    PLoS One; 2024; 19(5):e0303176. PubMed ID: 38728305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular evolution of SARS-CoV-2 from December 2019 to August 2022.
    Wolf JM; Wolf LM; Bello GL; Maccari JG; Nasi LA
    J Med Virol; 2023 Jan; 95(1):e28366. PubMed ID: 36458547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic analysis of SARS-CoV-2 reveals local viral evolution in Ghana.
    Ngoi JM; Quashie PK; Morang'a CM; Bonney JH; Amuzu DS; Kumordjie S; Asante IA; Bonney EY; Eshun M; Boatemaa L; Magnusen V; Kotey EN; Ndam NT; Tei-Maya F; Arjarquah AK; Obodai E; Otchere ID; Bediako Y; Mutungi JK; Amenga-Etego LN; Odoom JK; Anang AK; Kyei GB; Adu B; Ampofo WK; Awandare GA
    Exp Biol Med (Maywood); 2021 Apr; 246(8):960-970. PubMed ID: 33325750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and phylogenetic analysis of Iranian SARS-CoV-2 genomes: A phylogenomic study.
    Aliabadi N; Jamaliduost M; Pouladfar G; Marandi NH; Ziyaeyan M
    Health Sci Rep; 2023 Jan; 6(1):e1052. PubMed ID: 36686884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic characterization of SARS-CoV-2 in Egypt.
    Zekri AN; Easa Amer K; Hafez MM; Hassan ZK; Ahmed OS; Soliman HK; Bahnasy AA; Abdel Hamid W; Gad A; Ali M; Ali Hassan W; Samir Madboly M; Abdel Raouf A; Khattab AA; Salah El Din Hamdy M; Sherif Soliman M; Hamdi El Sissy M; Mohamed El Khateeb S; Hosny Ezzelarab M; Fathalla LA; Abouelhoda M
    J Adv Res; 2021 May; 30():123-132. PubMed ID: 33262895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic Diversity of SARS-CoV-2 in Algeria and North African Countries: What We Know So Far and What We Expect?
    Menasria T; Aguilera M
    Microorganisms; 2022 Feb; 10(2):. PubMed ID: 35208920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of Novel SARS-CoV-2 variants in India: second wave.
    Adiga R; Nayak V
    J Infect Dev Ctries; 2021 Nov; 15(11):1578-1583. PubMed ID: 34898481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the SARS-CoV-2 genomes in Egypt in first and second waves of infection.
    Zekri AN; Bahnasy AA; Hafez MM; Hassan ZK; Ahmed OS; Soliman HK; El-Sisi ER; Dine MHSE; Solimane MS; Latife LSA; Seadawy MG; Elsafty AS; Abouelhoda M
    Sci Rep; 2021 Nov; 11(1):21632. PubMed ID: 34732835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Indian SARS-CoV-2 Genomes Reveals Prevalence of D614G Mutation in Spike Protein Predicting an Increase in Interaction With TMPRSS2 and Virus Infectivity.
    Raghav S; Ghosh A; Turuk J; Kumar S; Jha A; Madhulika S; Priyadarshini M; Biswas VK; Shyamli PS; Singh B; Singh N; Singh D; Datey A; Avula K; Smita S; Sabat J; Bhattacharya D; Kshatri JS; Vasudevan D; Suryawanshi A; Dash R; Senapati S; Beuria TK; Swain R; Chattopadhyay S; Syed GH; Dixit A; Prasad P; ; ; Pati S; Parida A
    Front Microbiol; 2020; 11():594928. PubMed ID: 33329480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phylogenetic classification of the whole-genome sequences of SARS-CoV-2 from India & evolutionary trends.
    Potdar V; Vipat V; Ramdasi A; Jadhav S; Pawar-Patil J; Walimbe A; Patil SS; Choudhury ML; Shastri J; Agrawal S; Pawar S; Lole K; Abraham P; Cherian S;
    Indian J Med Res; 2021 Jan & Feb; 153(1 & 2):166-174. PubMed ID: 33818474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome sequence diversity of SARS-CoV-2 obtained from clinical samples in Uzbekistan.
    Abdullaev A; Abdurakhimov A; Mirakbarova Z; Ibragimova S; Tsoy V; Nuriddinov S; Dalimova D; Turdikulova S; Abdurakhmonov I
    PLoS One; 2022; 17(6):e0270314. PubMed ID: 35759503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the mutation dynamics of SARS-CoV-2 genome in the samples from Georgia State of the United States.
    Ahmad W; Ahmad S; Basha R
    Gene; 2022 Oct; 841():146774. PubMed ID: 35905853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Analysis of SARS-CoV-2 Circulating in Bangladesh during 2020 Revealed Lineage Diversity and Potential Mutations.
    Parvin R; Afrin SZ; Begum JA; Ahmed S; Nooruzzaman M; Chowdhury EH; Pohlmann A; Paul SK
    Microorganisms; 2021 May; 9(5):. PubMed ID: 34065789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of SARS-CoV-2 from Bangladesh: implications in genetic diversity, possible origin of the virus, and functional significance of the mutations.
    Rahman MM; Kader SB; Rizvi SMS
    Heliyon; 2021 Aug; 7(8):e07866. PubMed ID: 34458642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some common deleterious mutations are shared in SARS-CoV-2 genomes from deceased COVID-19 patients across continents.
    Islam MA; Marzan AA; Arman MS; Shahi S; Sakif TI; Hossain M; Islam T; Hoque MN
    Sci Rep; 2023 Oct; 13(1):18644. PubMed ID: 37903828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence and expansion of highly infectious spike protein D614G mutant SARS-CoV-2 in central India.
    Sharma S; Dash PK; Sharma SK; Srivastava A; Kumar JS; Karothia BS; Chelvam KT; Singh S; Gupta A; Yadav RG; Yadav R; Greeshma TS; Kushwaha PK; Kumar RB; Nagar DP; Nandan M; Kumar S; Thavaselvam D; Dubey DK
    Sci Rep; 2021 Sep; 11(1):18126. PubMed ID: 34518554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.